down arrow

Twist Bioscience Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90184D1000
USD
32.81
3.11 (10.47%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
ANI Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
Twist Bioscience Corp.
Xencor, Inc.
Merus NV
Vir Biotechnology, Inc.
Maravai Lifesciences Holdings, Inc.
Arcus Biosciences, Inc.
Summit Therapeutics, Inc.
Spyre Therapeutics, Inc.
Why is Twist Bioscience Corp. ?
1
Positive results in Jun 25
  • OPERATING CASH FLOW(Y) Highest at USD -51.14 MM
  • ROCE(HY) Highest at -17.58%
  • INVENTORY TURNOVER RATIO(HY) Highest at 6.76 times
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -32.95%, its profits have risen by 17.2%
3
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -32.95% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Twist Bioscience Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Twist Bioscience Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Twist Bioscience Corp.
-35.17%
-0.57
66.38%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
37.62%
EBIT Growth (5y)
-2.91%
EBIT to Interest (avg)
-182.69
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.55
Sales to Capital Employed (avg)
0.54
Tax Ratio
0.19%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.30
EV to EBIT
-10.56
EV to EBITDA
-12.84
EV to Capital Employed
8.32
EV to Sales
4.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-78.84%
ROE (Latest)
-33.22%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

29What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -51.14 MM

ROCE(HY)

Highest at -17.58%

INVENTORY TURNOVER RATIO(HY)

Highest at 6.76 times

DEBTORS TURNOVER RATIO(HY)

Highest at 8.62 times

NET SALES(Q)

Highest at USD 96.06 MM

RAW MATERIAL COST(Y)

Fallen by -23.88% (YoY

OPERATING PROFIT(Q)

Highest at USD -24.32 MM

OPERATING PROFIT MARGIN(Q)

Highest at -25.32 %

PRE-TAX PROFIT(Q)

Highest at USD 20.58 MM

NET PROFIT(Q)

Highest at USD 20.39 MM

EPS(Q)

Highest at USD 0.33

-6What is not working for the Company
INTEREST(9M)

At USD 0.17 MM has Grown at inf%

CASH AND EQV(HY)

Lowest at USD 507.94 MM

DEBT-EQUITY RATIO (HY)

Highest at -36.1 %

Here's what is working for Twist Bioscience Corp.
Operating Cash Flow
Highest at USD -51.14 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 96.06 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Pre-Tax Profit
At USD 20.58 MM has Grown at 150.88%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 20.39 MM has Grown at 150.17%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 6.76 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 8.62 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Profit
Highest at USD -24.32 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at -25.32 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 20.58 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 20.39 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.33
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -23.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Twist Bioscience Corp.
Interest
At USD 0.17 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Cash and Eqv
Lowest at USD 507.94 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -36.1 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Non Operating Income
Highest at USD 2.46 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."